insights_auto
Nega 2359 tushdi 2,19%?
Batafsil oʻrganishchevron_right
2359:HKG
WuXi AppTec Ord Shs H
196,20 HK$
arrow_downward
-2,19%(-4,40) 1K
16-okt, 16:08:14 (GMT+8) · HKD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto2359 tikeri uchun statistika yaratilmoqda...
Ochish
203,80 HK$
Yuqori
209,00 HK$
Past
185,00 HK$
Bozor kapitali
544,52 mlrd
Oʻrtacha hajm
3,91 mln
Hajmi
10,16 mln
Dividend
1,22%
Choraklik dividendlar
0,60 HK$
Eks-dividend sanasi
4-sen, 2026
P/E koeffitsiyenti
23,98
52 haftalik eng yuqori
219,20 HK$
52 haftalik eng past
96,70 HK$
Aksiya boʻyicha daromad
8,18 HK$
Xodimlar soni
36 ming
Ochish
203,80 HK$
Yuqori
209,00 HK$
Past
185,00 HK$
Bozor kapitali
544,52 mlrd
Oʻrtacha hajm
3,91 mln
Hajmi
10,16 mln
Dividend
1,22%
Choraklik dividendlar
0,60 HK$
Eks-dividend sanasi
4-sen, 2026
P/E koeffitsiyenti
23,98
52 haftalik eng yuqori
219,20 HK$
52 haftalik eng past
96,70 HK$
Aksiya boʻyicha daromad
8,18 HK$
Xodimlar soni
36 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
11 soat oldin
WuXi AppTec earns EcoVadis gold: what it means for WuXi AppTec stock
Profil
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
WuXi AppTec Ord Shs H haqida
CEOSteve Yang | Ge Li
Xodimlar soni35,6 ming
Asos solingan1-dek, 2000
Bosh ofislar-
Sektor-
Veb-saytwuxiapptec.com.cn